NYSE · GRDN
Guardian Pharmacy Services, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for GRDN: Nov 05, 2026
Guardian Pharmacy Services, Inc. Class A Common Stock is expected to report earnings on 11/05/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $0.28. The reported EPS for the same quarter last year was $0.19.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.28 | $0.30 | $0.27 | 3 |
| Dec 2026 | $0.38 | $0.40 | $0.36 | 3 |
| Mar 2027 | $0.27 | $0.28 | $0.27 | 3 |
| Jun 2027 | $0.30 | $0.31 | $0.28 | 3 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · Fintel · The Motley Fool · MarketBeat- Zacks · Sep 29, 1:35 AM EDTZacks.com featured highlights include CNXN, ECG, GRDN, EXPD and PBFDuPont analysis highlights CNXN, ECG, GRDN, EXPD and PBF, with strong earnings surprises supporting the screen's stock picks.
- Zacks · Sep 28, 7:52 AM EDTBet on Winning DuPont Analysis & Pick 5 Top StocksDo you have more faith in DuPont analysis than simple ROE calculation? Tap CNXN, ECG, GRDN, EXPD and PBF.
- Fintel · Sep 23, 9:49 AM EDTKeybanc Initiates Coverage of Guardian Pharmacy Services at OverweightFintel reports that on September 23, 2026, Keybanc initiated coverage of Guardian Pharmacy Services (NYSE:GRDN) with a Overweight recommendation. Prior to this action, the stock closed at $44.67 on September 22, 2026. This latest close reflects a one-week price change of -6.94% f
- The Motley Fool · Aug 13, 7:44 PM EDTGuardian Pharmacy Services (GRDN) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 8, 6:03 AM EDTGuardian Pharmacy Services Q2 Earnings Call Highlights5 Small-Cap Stocks With Impressive Growth and Upside PotentialGuardian Pharmacy Services (NYSE:GRDN) reported second-quarter revenue growth of 2% year over year to $351.2 million, while adjusted EBITDA increased 19% to $29.7 million, as the company said it continued to offset pro
- Zacks · Aug 6, 7:10 PM EDTGuardian Pharmacy Services (GRDN) Q2 Earnings and Revenues Top EstimatesGuardian Pharmacy (GRDN) delivered earnings and revenue surprises of +11.54% and +3.57%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jul 8, 10:37 AM EDTXeris Biopharma (XERS) Moves 6.8% Higher: Will This Strength Last?Xeris Biopharma (XERS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- Zacks · Jun 30, 9:30 AM EDTZacks.com featured highlights include Casey's General Stores, Everus Construction, Guardian Pharmacy Services, Expeditors International of Washington and Mama's CreationsDuPont analysis can uncover stronger stock picks by breaking down ROE, with five companies standing out on profitability, efficiency and leverage metrics.
- Zacks · Jun 29, 5:51 AM EDTGuardian Pharmacy (GRDN) Surges 8.8%: Is This an Indication of Further Gains?Guardian Pharmacy (GRDN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- Zacks · Jun 11, 9:15 AM EDTAMNEAL PHARMACEUTICALS, INC. (AMRX) Hits Fresh High: Is There Still Room to Run?Amneal (AMRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- Zacks · Jun 8, 9:15 AM EDTGuardian Pharmacy Services, Inc. (GRDN) Hit a 52 Week High, Can the Run Continue?Guardian Pharmacy (GRDN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- MarketBeat · May 10, 1:14 PM EDTGuardian Pharmacy Services Q1 Earnings Call Highlights5 Small-Cap Stocks With Impressive Growth and Upside PotentialGuardian Pharmacy Services (NYSE:GRDN) reported what executives described as a solid first quarter of 2026, with management saying the company successfully navigated the initial implementation of the Inflation Reductio
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Guardian Pharmacy Services, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.